Patents by Inventor Kurt Gerard Klem

Kurt Gerard Klem has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11532826
    Abstract: A method for operating a medical device includes activating a processor in the medical device in a low-power operating mode, measuring a first voltage level of the battery, applying at least one discharge pulse to the battery in response to the first voltage level of the battery being greater than a predetermined passivation minimum voltage threshold and less than a predetermined passivation maximum voltage threshold, measuring a second voltage level of the battery after the at least one discharge pulse, and operating the processor in the medical device in an increased-power operating mode to continue operation of the medical device only in response to the second voltage level being greater than or equal to a predetermined operating voltage threshold, the predetermined operating voltage threshold being greater than the predetermined passivation minimum voltage threshold and less than or equal to the predetermined passivation maximum voltage threshold.
    Type: Grant
    Filed: December 19, 2019
    Date of Patent: December 20, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Larry Lewis Lockridge, Duane Patrick Fridley, Kurt Gerard Klem, Michael Joseph Blackburn, Nathan Eugene Manlove, Steven Kent Moore, Marshall M. Parker
  • Publication number: 20210186384
    Abstract: A method for operating a medical device includes activating a processor in the medical device in a low-power operating mode, measuring a first voltage level of the battery, applying at least one discharge pulse to the battery in response to the first voltage level of the battery being greater than a predetermined passivation minimum voltage threshold and less than a predetermined passivation maximum voltage threshold, measuring a second voltage level of the battery after the at least one discharge pulse, and operating the processor in the medical device in an increased-power operating mode to continue operation of the medical device only in response to the second voltage level being greater than or equal to a predetermined operating voltage threshold, the predetermined operating voltage threshold being greater than the predetermined passivation minimum voltage threshold and less than or equal to the predetermined passivation maximum voltage threshold.
    Type: Application
    Filed: December 19, 2019
    Publication date: June 24, 2021
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Larry Lewis Lockridge, Duane Patrick Fridley, Kurt Gerard Klem, Michael Joseph Blackburn, Nathan Eugene Manlove, Steven Kent Moore, Marshall M. Parker
  • Patent number: 7401111
    Abstract: A method of configuring a hand-held instrument (10) for determining the concentration of a medically significant component of a body fluid or a control comprises providing a configuring computer (14) having a first port (18) for transmitting instructions and data for configuring the instrument (10), providing on the instrument (10) a second port (17) for receiving the instructions and data from the configuring computer (14), coupling the first port (18) to the second port (17), transmitting instructions and data to configure the instrument (10) from the first port (18), receiving the instructions and data at the second port (17), and configuring the instrument (10) according to the instructions and data transmitted from the first port (10) and received at the second port (17).
    Type: Grant
    Filed: December 4, 1998
    Date of Patent: July 15, 2008
    Assignee: Roche Diagnostic Operations, Inc.
    Inventors: Carol Jane Batman, Nancy Kennedy Byrd, Timothy J. Dishop, Les G Henderson, Patricia A. Hopkinson, Stephen E. Moak, James R. Parker, Frank M. Polaski, Atwell R. Shearer, Tracy Knudsen, Lynne Denise Sly, Kurt Gerard Klem
  • Patent number: 6635167
    Abstract: An instrument (20) has a well (28a-b) for receiving a dry cell (75), an opening (78) through which a first connector (74) is exposed to the well (28a-b), and a boss (76) adjacent the opening (78). The boss (76) precludes the wrong terminal of the dry cell (75) from engaging the first connector (74) when the dry cell (75) is inserted into the well (28a-b) in incorrect orientation. A second connector (80) includes a base (81), a first leg (82) resiliently connected to and extending away from the base portion, a second leg (84) resiliently connected to and extending away from the first leg (82), and a third leg (86) resiliently connected to and extending away from the second leg (84) and toward the first leg (82). A display (42) for the instrument (20) has a lens (90) having a substantially transparent substrate with a polyurethane coating. The instrument housing has first and second portions.
    Type: Grant
    Filed: November 21, 2000
    Date of Patent: October 21, 2003
    Assignee: Roche Diagnostics Corporation
    Inventors: Carol Jane Batman, Greg Paul Carpenter, Robert Glenn Davies, Richard J. Kasle, Kurt Gerard Klem, Robert Anthony Parks, Timothy L. Ranney, William Brothers, Christopher Louis Belisle, Michael Steven Ray, Leonard Allen Vetsch, Marvin W. Glass, Richard W. Wilson, James R. Parker, Vladimir Svetnik, Lynne Denise Sly, Sandy Mark Richards, Nancy Kennedy Byrd, Patricia A. Hopkinson